ScholarLens Back to search
2001•Current Opinion in UrologyRequires access

Safety, efficacy and impact on patients’ quality of life of a long-term treatment with α1-blocker alfuzosin in symptomatic patients with BPH.

Andrea Tubaro

Open publisher page 0 citations

Abstract

Correspondence to Mr Christopher R. Chapple, Urology Research Department, Royal Hallamshire Hospital, Glossop Road, Sheffield S10 2JF, UK. Tel: +44 114 271 2791; fax: +44 114 279 8318

About this research paper

What this paper is about

Correspondence to Mr Christopher R. Chapple, Urology Research Department, Royal Hallamshire Hospital, Glossop Road, Sheffield S10 2JF, UK. Tel: +44 114 271 2791; fax: +44 114 279 8318

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Correspondence to Mr Christopher R. Chapple, Urology Research Department, Royal Hallamshire Hospital, Glossop Road, Sheffield S10 2JF, UK. Tel: +44 114 271 2791; fax: +44 114 279 8318

Key concepts: Medicine, Alfuzosin, Urology, Quality of life (healthcare), Tamsulosin, Gynecology, Internal medicine, Nursing

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Safety, efficacy and impact on patients’ quality of life of a long-term treatment with α1-blocker alfuzosin in symptomatic patients with BPH. — Research Paper | ScholarLens